Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
11.78
+0.11 (0.94%)
At close: Aug 19, 2026, 4:00 PM EDT
11.98
+0.20 (1.68%)
After-hours: Aug 19, 2026, 7:55 PM EDT
Cybin Employees
Cybin had 100 employees as of March 31, 2026. The number of employees increased by 50 or 100.00% compared to the previous year.
Employees
100
Change (1Y)
50
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$1,712,040
Market Cap
730.17M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 100 | 50 | 100.00% |
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| 4D Molecular Therapeutics | 196 |
| Allogene Therapeutics | 152 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 106 |
| CytomX Therapeutics | 69 |
| Crescent Biopharma | 69 |
HELP News
- 1 day ago - Helus Pharma appoints Regina Donohue as chief people officer - TheFly
- 1 day ago - Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board - GlobeNewsWire
- 5 days ago - Cybin Earnings release: Q1 2027 - Filings
- 5 days ago - Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 days ago - Cybin Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 14 days ago - Helus Pharma appoints Michael Halstead as CEO - TheFly
- 16 days ago - Helus Pharma Appoints Michael Halstead as Chief Executive Officer - GlobeNewsWire
- 23 days ago - Helus Pharma initiated with an Overweight at Wells Fargo - TheFly